In the News with GMI
In the News

Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease

Heart Disease: Signs and Symptoms
Heart disease is an umbrella term that encompasses many different illnesses linked to heart and blood vessels. According to the Mayo Clinic, some of these

Stress and Diabetes: How It Can Affect You
Your body reacts to stress or threat by releasing adrenaline and cortisol through the fight-or-flight response. If your body cannot process these hormones efficiently, it

Acid Reflux and GERD: Managing Your Symptoms
Acid reflux, also called acid regurgitation or gastroesophageal reflux, happens when contents from your stomach come back up into your esophagus. If you have symptoms

Nasal Polyps: The Signs and Symptoms to Look Out For
Nasal polyps are noncancerous growths that dangle like teardrops or grapes from the membrane in your nasal passages or sinuses. They have a soft texture

The Difference Between Migraines and Headaches
Although migraines affect over 37 million people in the United States, fewer than 5% of those affected have been correctly diagnosed and treated. Before you
News Archives
Contact Us Today
Clinical Treatments Include:

Global Medical Institutes (GMI) is an Investigative Research Company which conducts Phase I-IV human clinical trials for the pharmaceutical, biotechnology and medical devices industry through our network of wholly-owned and affiliated clinical research facilities.
GLOBAL MEDICAL INSTITUTES
CORPORATE OFFICE:
Woodlands Proefssional Buildings
256 Bunn Drive, Suite 6 Princeton, NJ 08540
OFFICE HOURS:
Mon-Fri: 9:00 AM – 5:30 PM
Sat-Sun: Closed
CONTACT INFO:
Phone: (609) 921-6050